Comparing Caplyta vs Invega Sustenna
Caplyta Remove Caplyta from your drug comparison | Invega Sustenna Remove Invega Sustenna from your drug comparison |
---|
Caplyta lumateperone Remove Caplyta from your drug comparison | Invega Sustenna paliperidone Remove Invega Sustenna from your drug comparison | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caplyta is an atypical antipsychotic that may be used to treat adults with schizophrenia. Sedation is the most common side effect and it should not be used in people with moderate to severe liver... View more |
Prescribed for Schizoaffective Disorder, Schizophrenia. Invega Sustenna may also be used for purposes not listed in this medication guide. |
||||||||||||||||
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
See the full Caplyta side effects document. |
See the full Invega Sustenna side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Caplyta prices |
View all Invega Sustenna prices and generic prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
No |
|||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
N/A |
Other paliperidone brands include: Invega, Invega Trinza | ||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
18 hours |
23 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
Summary unavailable. See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
N/A |
|||||||||||||||||
Drug Interactions |
|||||||||||||||||
A total of 543 drugs are known to interact with Caplyta:
|
A total of 587 drugs are known to interact with Invega Sustenna:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
|||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
December 20, 2019 |
July 31, 2009 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.